Skip to content
10-Q

Quarterly Report

Biohaven Ltd. BHVN

0001935979-26-000045

← back to feed
Filed
May 4, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 150.56M sh
Shares Diluted Q1 2026 · Mar 31, 2026 147.62M sh
Shares Diluted Q1 2026 · Mar 31, 2025 101.94M sh
Capex Q1 2026 · Mar 31, 2026 $0
Capex Q1 2026 · Mar 31, 2025 $461K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$149.92M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$165.12M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $273.07M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $229.96M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $98.42M
Stockholders Equity Q1 2026 · Mar 31, 2026 $129.5M
Stockholders Equity Q1 2026 · Dec 31, 2025 $52.07M
Current Liabilities Q1 2026 · Mar 31, 2026 $52.08M
Current Liabilities Q1 2026 · Dec 31, 2025 $115.93M
Total Liabilities Q1 2026 · Mar 31, 2026 $336.91M
Total Liabilities Q1 2026 · Dec 31, 2025 $399.38M
Current Assets Q1 2026 · Mar 31, 2026 $385.65M
Current Assets Q1 2026 · Dec 31, 2025 $368.33M
Total Assets Q1 2026 · Mar 31, 2026 $466.41M
Total Assets Q1 2026 · Dec 31, 2025 $451.45M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.88
Eps Diluted Q1 2026 · Mar 31, 2025 −$2.17
Eps Basic Q1 2026 · Mar 31, 2026 −$0.88
Eps Basic Q1 2026 · Mar 31, 2025 −$2.17
Sga Expense Q1 2026 · Mar 31, 2026 $26.6M
Sga Expense Q1 2026 · Mar 31, 2025 $33.98M
Rd Expense Q1 2026 · Mar 31, 2026 $103.83M
Rd Expense Q1 2026 · Mar 31, 2025 $187.58M
Net Income Q1 2026 · Mar 31, 2026 −$130.53M
Net Income Q1 2026 · Mar 31, 2025 −$221.68M
Operating Income Q1 2026 · Mar 31, 2026 −$130.43M
Operating Income Q1 2026 · Mar 31, 2025 −$221.56M